Blueprint Medicines Corp buy BiotechBee
Start price
07.09.22
/
60%
€74.46
Target price
31.12.24
€100.00
Performance (%)
-29.49%
End price
05.05.23
€52.50
Summary
This prediction ended on 05.05.23 with a price of €52.50. The price of Blueprint Medicines Corp has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -29.49%. BiotechBee has 60% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Blueprint Medicines Corp | - | - | - | - |
| iShares Core DAX® | 2.659% | 4.844% | 23.110% | 68.731% |
| iShares Nasdaq 100 | 0.916% | -0.554% | 6.985% | 113.533% |
| iShares Nikkei 225® | 2.426% | 1.598% | 15.780% | 50.934% |
| iShares S&P 500 | 1.230% | 1.039% | 4.695% | 68.205% |
According to BiotechBee what are the pros and cons of Blueprint Medicines Corp for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Blueprint Medicines Corp diskutieren
Buy mit Kursziel 100,0